Multidomain therapy for Alzheimer's disease: a scoping review of cognitive decline trials.

Publication Title

Mol Neurodegener

Authors

• Jared C Roach, Institute for Systems Biology, Seattle, WA USAFollow
• Gwênlyn Glusman, Institute for Systems Biology, Seattle, WA USA
• Molly K Rapozo, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
• David A Merrill, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
• Jennifer Bramen, Pacific Neuroscience Institute, Santa Monica, CA, USA, Saint John's Cancer Institute, Santa Monica, CA, USA.Follow
• John F Hodes, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
• Prabha Siddarth, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
• Somayeh Meysami, Pacific Neuroscience Institute, Santa Monica, CA, USA, Saint John's Cancer Institute, Santa Monica, CA, USA.Follow
• Shannel H K Elhelou, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
• Ryan M Glatt, Pacific Neuroscience Institute, Santa Monica, CA, USAFollow
• Lance Edens, Institute for Systems Biology, Seattle, WA USA
• Cory Funk, Institute for Systems Biology, Seattle, WA USA
• Dan Kelly, Pacific Neuroscience Institute, Santa Monica, CA, USA
• William R Shankle
• Dale Bredesen, Pacific Neuroscience Institute, Santa Monica, CA, USA
• Cyrus A Raji
• Leroy Hood, Institute for Systems Biology, Seattle, WA USAFollow

Document Type

Article

Publication Date

11-22-2025

Keywords

washington; isb; california; pni; pacific neurosci

Area of Special Interest

Neurosciences (Brain & Spine)

Area of Special Interest

Mental Health

Specialty/Research Institute

Neurosciences

Specialty/Research Institute

Behavioral Health

DOI

10.1186/s13024-025-00912-2